Dossier
Parabilis
Coverage of Parabilis in the Nexus archive.
- Drugmaker Parabilis Raises $745 Million in US IPO, Placement
Drugmaker Parabilis raised $745 million through a US IPO and placement. The funding round includes both an initial public offering and a placement.
- Cancer Drugmaker Parabilis Seeks $475 Million in US IPO
Cancer drugmaker Parabilis is seeking $475 million through a US IPO. The article references an MRI scan depicting lung cancer in the left pulmonary lobe.